Sydney, Australia and Minneapolis, MN USA – 27 November 2018: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company announces that it has signed an exclusive agreement with AIAA to undertake a pilot program for [...]
Sydney, Australia and Minneapolis, MN USA – 16 November 2018: Medibio Limited (MEB or the Company) (ASX: MEB) (OTCQB: MDBIF), a mental health technology company, today provides an update regarding the Annual General Meeting held in Melbourne on Friday, 16 November 2018. Read [...]
Medibio Provides Update on FDA Process Sydney, Australia and Minneapolis, MN USA – 9 November 2018: Medibio Limited (MEB or the Company) (ASX: MEB) (OTCQB: MDBIF), a mental health technology company, today provides an update regarding the current De Novo [...]
Medibio Appoints Global Healthcare & Medical Device Leader as CEO and Managing Director Sydney, Australia and Minneapolis, MN USA – 2 November 2018: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, announces the [...]
